This information was published on 2025-01-27T08:35:32 for IP Right Registration Published.
| Field | Value |
| (210) | 2498799 (IR 1822397) |
| (220) |
13 Aug 2024
|
| (300) |
GB, 14 Feb 2024, UK00004014230
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, urothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, hodgkin's lymphoma, and head and neck cancers. |
| (540) | KYOPRAME |
| (550) | Word |
| (730) |
Immunocore Limited
|
Find out more about publications on the About page.